Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. - Wikidata - wikimedia - TriplyDB

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

http://www.wikidata.org/entity/Q35865986

about

Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures Genetic correlates influencing immunopathogenesis of HIV infection Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?CD8(+)T-cell-mediated control of HIV-1 and SIV infection.Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.HIV subtype influences HLA-B*07:02-associated HIV disease outcome.Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.Distinct assembly profiles of HLA-B molecules.Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.Primate-specific regulation of natural killer cells.HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications.HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.DCs and NK cells: critical effectors in the immune response to HIV-1.Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.Human genes that limit AIDS.CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types

P2860

Q24682861-E29B8314-C546-4EF7-833F-44B5004C1927 Q24798326-29219306-3757-46E9-9126-E2676FE4DD4F Q26827459-61803989-8ECB-4B8A-B6F7-32DE2433E873 Q27322468-54A2D03D-A21A-4D13-B6DF-42C32BE47185 Q29417018-8BDBF40F-4526-4A16-A49D-8F952EFAA0EC Q30362489-1A29A61D-6D2F-4A8E-B3C3-32E8E59D671F Q30397667-9B270102-382E-4F37-BFC5-A8EAA6922E3D Q30413217-A3A0DCE4-69CF-40C9-917C-F6AB7012F9E7 Q33318083-AE649287-85E6-49C3-B9D6-1B63C0137405 Q33566546-9F8FDB20-38C4-4AF3-A3E4-B8472942567D Q33648970-23C6781F-54CB-49F9-AD21-4CF9E0A68AD9 Q33741498-1417298C-CE22-442D-819A-B07271DE0189 Q33828392-6C07BF46-E255-4EEE-B9E7-E512F7B0DE70 Q33854564-91EDED3D-4D75-491A-BFC2-140CAAD0EB1D Q33869925-C1C18A05-526A-4AED-A2A7-CABFEF786C50 Q33911914-B9A8E12C-5EBB-432C-879D-992F68E4FEE4 Q33918894-7AEFED9F-4E8C-468A-A008-8AA65F4CEE65 Q33981529-51E4B71D-48F1-40BB-8DE8-20E8529B1611 Q33999689-23F2536E-02D8-43D6-B187-25A12934FBF7 Q34056087-7FB01557-5B8D-4302-9005-3CA68E7D8F35 Q34064807-9A94CB60-6D4F-4BCA-A178-9F4CAC5F5CFC Q34341384-C1C59DC6-A147-405B-A361-D0CFA359E882 Q34397564-413FBC8A-2AB6-43FD-AA25-7542884F0032 Q34448446-940909FC-B509-4912-B8DE-B1F7C9E78CEE Q34559322-8B8E0C67-E774-4B28-9842-35D6D34DBDA0 Q34769696-49057C59-18D2-4AEA-82D5-BB92F50AD6F3 Q34995326-4475D467-416F-4C9C-AB61-6DC87B8568FC Q35030951-D7BB8C11-42AB-4E2F-9D5E-E7E5A116AD88 Q35076703-08DBE4E5-79D7-4F06-8D74-7EC014EA04DE Q35077067-BC2D9B78-3AF7-4389-9732-4B2AB98A76CE Q35121645-B8F7D3A0-64BF-48E2-B861-209858F1FD15 Q35126671-4ABA6B7A-ADA4-49D1-B31B-ADCB773ACEBA Q35145382-3F82F24B-5071-4221-A572-8148451BD186 Q35275215-F27DFBEC-B9E6-41EF-9049-405062FDCB6F Q35567805-CE034C73-95A5-495F-BA84-EA0ACB04090D Q35749755-AF528FE2-5FE7-4E44-AD68-FAB94FCC4245 Q35752667-7FDEB763-E6DB-46FF-B609-76CC6CE470C2 Q35753686-658E2BEE-3FA7-483D-8844-CBF5F118EB17 Q35787248-176021B7-3F40-4628-97AD-345FEBCB5EDC Q35797743-7CBEE080-46EC-4E0F-BE76-FC312E892400

P2860

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

http://www.wikidata.org/entity/Q35865986

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@ast

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@en

type

label

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@ast

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@en

prefLabel

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@ast

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@en

P1433

Q35865986-AD56ECEF-F486-4720-BD18-19F2A4146A50

P1476

Q35865986-876D07A1-48B4-405F-BE1B-01D04B4A52F6

P2093

Q35865986-0ABF26B9-A9C5-4BF8-8390-AB3FB3D6D926

Q35865986-21BBF479-3D0C-485E-A7D6-0AAA3A420797

Q35865986-4D46DC93-4776-4128-82A9-3D94052B0E92

Q35865986-4EF01778-1244-4111-9748-FFDDF4E2FF64

Q35865986-5BDBA4A9-2D06-4CBC-A8A4-5B7A769584CF

Q35865986-71B2FA00-9EB2-4941-ABF7-DC13663FD288

Q35865986-7C092C40-24D0-4DF7-8C09-39845F5F6196

Q35865986-9874383A-1B8D-4E61-8707-A57058616F85

Q35865986-CD25C054-D073-4E18-9C84-ACEC638BAA76

Q35865986-CE735CE7-48AA-4CB0-A92E-1D13F787FE1B

P2860

Q35865986-00A0AB80-B9FC-4171-AB82-A9A475EEC56D

Q35865986-0DD0AC8E-DB04-4189-AE82-0E9393F18F90

Q35865986-21F40243-9E9B-4625-A2D7-708BFEE91FD6

Q35865986-2D18757F-6432-4CC4-9565-99F73548ED9B

Q35865986-2EB4B827-160A-4D52-8581-21CBA689E886

Q35865986-3A15C530-25F4-45D8-95C2-CBDBBD07479D

Q35865986-3DF47CE3-E8AC-4301-8640-879CD7DB8BA2

Q35865986-4183BD13-7B0D-4F3F-9963-7C40F6F64AA4

Q35865986-4690C14C-F9C7-4628-922B-8D19BEB294F0

Q35865986-4F04987B-8240-4C8C-A111-A67C608EC0A8

P304

Q35865986-659D6DCA-9E89-40BA-B066-6C57CFD1C681

P31

Q35865986-1E811639-30FD-4EB7-A928-30EC7FB43C57

P356

Q35865986-6C853418-80F1-48F2-9187-97AD054144C7

P407

Q35865986-8F06A25C-D089-4D03-A461-597694A5B974

P433

Q35865986-A43E190B-6118-45A3-81F3-1C35A637C8ED

P478

Q35865986-D4898609-BE64-4330-AA23-74102AECE872

P577

Q35865986-F2B700B4-8673-4CEA-AAEC-9D955385599D

P5875

Q35865986-2377847A-0647-463B-A898-F6531AB707D7

P698

Q35865986-FBC6DEDB-E5A5-4DB6-873E-B3403F23DD3D

P932

Q35865986-36A61B3B-D1E7-48B4-B6A4-8846E5974933

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Control of HIV-1 viremia and p ...... ted with HLA-Bw4 homozygosity.

@en

P2093

A E Goldfeld

http://www.w3.org/2001/XMLSchema#string

A M Uglialoro

http://www.w3.org/2001/XMLSchema#string

B D Walker

http://www.w3.org/2001/XMLSchema#string

E J Yunis

http://www.w3.org/2001/XMLSchema#string

E S Rosenberg

http://www.w3.org/2001/XMLSchema#string

E Vittinghoff

http://www.w3.org/2001/XMLSchema#string

J C Delgado

http://www.w3.org/2001/XMLSchema#string

J D Braun

http://www.w3.org/2001/XMLSchema#string

J Y Leung

http://www.w3.org/2001/XMLSchema#string

O P Clavijo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

P304

5140-5145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.071548198

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12024114

http://www.w3.org/2001/XMLSchema#string

P698

11309482

http://www.w3.org/2001/XMLSchema#string

P932

33177

http://www.w3.org/2001/XMLSchema#string